Lithium salicylate
 | |
| Names | |
|---|---|
| IUPAC name
lithium 2-hydroxybenzoate
| |
| Identifiers | |
| ChemSpider | |
PubChem CID
|
|
| UNII | |
| Properties | |
| C7H5LiO3 | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Lithium salicylate (C7H5LiO3) is a crystalline salt of salicylic acid and lithium used in medicine and materials.[1][2][3] Lithium cocrystal, a combination of lithium salicylate and the amino acid L-proline, is under development as a drug for Alzheimer's disease, bipolar disorder, and other uses.[4][5]
See also
[edit]References
[edit]- ^ "Lithium salicylate". Chem-Impex. Retrieved 2026-01-09.
- ^ "Lithium Salicylate (CAS 552-38-5) | SAM". www.samaterials.com. Retrieved 2026-01-09.
- ^ "Lithium salicylate (Salicylic acid lithium) | Salicylate Lithium Salt | MedChemExpress". MedchemExpress.com. Retrieved 2026-01-09.
- ^ Smith, Adam J.; Kim, Seol-Hee; Duggirala, Naga K.; Jin, Jingji; Wojtas, Lukasz; Ehrhart, Jared; Giunta, Brian; Tan, Jun; Zaworotko, Michael J.; Shytle, R. Douglas (2013-12-02). "Improving lithium therapeutics by crystal engineering of novel ionic cocrystals". Molecular Pharmaceutics. 10 (12): 4728–4738. doi:10.1021/mp400571a. ISSN 1543-8392. PMC 3850245. PMID 24191685.
- ^ "Lithium: 12 Updates from 2023 | CARLAT PUBLISHING". www.thecarlatreport.com. Retrieved 2026-01-09.